Icf Intl Inc Stock Price, News & Analysis

ICF (NASDAQ: ICFI) has appointed Michelle A. Williams, dean of the Harvard T.H. Chan School of Public Health, to its board of directors effective December 1, 2021. Williams brings extensive experience as an epidemiologist and academic leader, having published over 500 peer-reviewed papers. ICF CEO John Wasson expressed enthusiasm for her joining, highlighting her expertise in public health as a strong asset for the company. Williams aims to support ICF in tackling complex challenges and enhancing community resilience. This strategic addition strengthens ICF's leadership in addressing pressing global issues.

ICF reported third-quarter 2021 revenue of $394 million, a 9% rise from last year, with service revenue at $276 million, up 4%. Diluted EPS increased to $1.07, a 14% increase. The company secured $604 million in new contracts, resulting in a trailing twelve-month contract total of $2.1 billion. The backlog stood at $3.1 billion, with 55% funded. ICF announced the acquisition of ESAC to enhance its public health services. Despite a decline in commercial revenue, strong growth in government revenue (up 16.1%) supports future growth, with revised EPS guidance for 2021 reflecting significant expected growth.

ICF (NASDAQ:ICFI) has acquired ESAC, a specialized provider of advanced health analytics and bioinformatics, enhancing its capabilities in federal health agencies. This acquisition aims to address the increasing complexity of health data and interoperability requirements in the U.S. federal health sector. With a strong cultural alignment, ICF plans to leverage ESAC's expertise in health IT and data standards to capture growth opportunities. The 40-person ESAC team has extensive experience since 2006, supporting research and healthcare quality improvements.

The U.S. Department of Health and Human Services awarded ICF $24 million in technical assistance contracts to enhance programs under the Administration for Children and Families. The agreements include a $15 million contract focused on human trafficking prevention, a $5 million extension for early childhood education support, and a $4 million contract for low-income water assistance programs. ICF has over 30 years of experience aiding ACF programs, aiming to improve the social well-being of children and families nationwide.

The U.S. Department of Justice has awarded ICF a $20 million contract to provide training and technical assistance to the Bureau of Justice Assistance's National Training and Technical Assistance Center (BJA NTTAC). The contract spans five years, consisting of a one-year base and four one-year options. ICF will leverage over 20 years of experience in supporting similar services to enhance the criminal justice system by reducing crime and recidivism. This partnership aims to deliver impactful solutions and support for state, local, and tribal justice agencies.

The CDC has awarded ICF (NASDAQ:ICFI) three contracts totaling $35 million for digital transformation and health services. The largest, worth $15 million, focuses on modernizing HIV clinical surveillance systems over a five-year term. An $11 million contract supports cancer surveillance systems, and a $9 million task order involves tobacco control communications and marketing. ICF's long-standing relationship with the CDC underscores its capabilities in addressing public health challenges.

The CDC has awarded ICF a $31 million contract for a four-year term to enhance the BioSense syndromic surveillance platform. This recompete contract includes a one-year base period and three optional extensions. ICF will collaborate with the CDC to improve national health monitoring capabilities, crucial for responding to public health threats like COVID-19. ICF has supported BioSense since 2014, providing essential operational and technical support for various health crises.

ICF has announced that it will release its third quarter 2021 results on November 2, 2021, after market close. Interested parties can access the results at investor.icf.com. A conference call to discuss these results is scheduled for 4:30 p.m. ET on the same day, with registration available at this link. Investors can dial 1.888.771.4371 to participate, using confirmation number 5023 5759.

The National Cancer Institute (NCI) has awarded ICF a new $150 million indefinite delivery, indefinite quantity (IDIQ) contract for biomedical technical and data management support services. This 5-year contract allows ICF to leverage its expertise in bioinformatics, health research, and health IT to support NCI studies. The company will deliver various services, including analytics, project management, and cloud-native biomedical computing. ICF's track record in public health positions it well to meet NCI's rigorous needs, enhancing cancer research infrastructure.